CClinicalTrials.gg
CompletedNCT03939676Updated Jul 29, 2021

Evaluating Motivation and Reward Mechanisms and Brain Substrates in Adults With Obesity

An observational study in Anhedonia and Obesity, sponsored by Brain and Cognition Discovery Foundation. Completed at 1 site in Canada. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2021-07-29.

Sponsored by Brain and Cognition Discovery Foundation · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
12
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Anhedonia and abnormalities in reward behavior are core features of overweight/obesity (OW), a highly prevalent condition within MDD populations, and is independently associated with reward disturbances. The investigators therefore aim to investigate the brain substrates subserving reward and motivation in adults with overweight/obesity.

The primary aim of this pilot study is to determine whether associations exist between obesity and decreased performance on the respective motivation/reward paradigms.

Read the detailed description

Herein, the investigators are primarily interested in three overlapping, yet distinct aspects, of anhedonia. The investigators are primarily interested in motivation, reward valuation, and reward learning towards addressing the measurement of each of these respective subdomains, eligible participants will complete validated gold standard measures (i.e. the Effort Expenditure for Rewards Task (EEfRT) (reward valuation), Probabilistic Reward Task (PRT) (reward learning), and the Monetary Incentive Delay (MID) task (reward anticipation)).

Twenty adults with overweight/obesity will complete all tasks at a single visit with two of the tasks being completed prior to MRI and one of the tasks (i.e. EEfRT) will be completed during MRI acquisition.

The primary aim of this pilot study is to determine whether associations exist between obesity and decreased performance on the respective motivation/reward paradigms. In addition, associations between performance on reward tasks and functional connectivity, as measured by MRI and DTI, a secondary objective is to ascertain whether associations exist between performance on the motivation reward tasks and gold standard measures of food intake (i.e. food diary) and energy expenditure (i.e. calorimetry).

02

Conditions studied

  • Anhedonia
  • Obesity
03

In context

Anhedonia

119 studies on the registry are indexed under Anhedonia; 44 are open to participants now.

This study's enrollment of 12 is below the median of 80 across 18 observational studies indexed under Anhedonia.

Browse Anhedonia studies →

Lead sponsor

Brain and Cognition Discovery Foundation is the lead sponsor of 8 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Participants will be identified at the Brain and Cognition Discovery Foundation (BCDF). Twenty subjects between the ages of 18-65 years with obesity, will be enrolled. All patients will be assessed for concurrent psychiatric disorders (e.g. mood disorders) and will meet DSM-V criteria for either: major depressive disorder (symptomatic or asymptomatic in any phase of the illness) or bipolar disorder I/II (symptomatic or asymptomatic in any phase of the illness).

Inclusion criteria

  • 18-65 years of age
  • Meeting DSM-V criteria for: (i) Major depressive disorder (symptomatic or asymptomatic in any phase of the illness) or (ii) bipolar disorder I/II (symptomatic or asymptomatic in any phase of the illness)
  • Ability to provide written and informed consent
  • Obesity 30 kg/m2
  • Weight under 440lbs
  • Shoulder-to-shoulder width under 60 cm

Exclusion criteria

Exclusion Criteria:

  • Age below 18 or above 65
  • Use of benzodiazepines or consumption of alcohol within 12 hours of assessments
  • Abuse of marijuana
  • Physical, cognitive, or language impairments sufficient to adversely affect data derived from assessments
  • Diagnosed reading disability or dyslexia
  • Clinically significant learning disorder by history
  • History of moderate or severe traumatic brain injury
  • Other neurological disorders, or unstable systemic medical diseases
  • Pregnancy and post-partum period
  • Presence of any contra-indications for MRI
  • Weight above 440lbs
  • Shoulder-to-shoulder width greater than 60 cm.

All subjects will be consented prior to initiating the study; >45 BMI; suicidality as determined by clinical discretion

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
12 participants (actual)
Patient registry
No

Groups and cohorts

  • Major Depressive Disorder or Bipolar Disorder

    All eligible participants will be included in this single study arm.

06

What researchers measure

Primary outcomes

  1. Effort Expenditure for Rewards Task (EEfRT)

    The EEfRT task is a behavioural paradigm that is used to investigate the subject's effort-based decision-making. Subjects are presented with a series of repeated trials wherein they must choose between performing a hard task or an easy task in order to receive monetary compensation (subject's will receive greater compensation for completing the hard task and less compensation for completing the easy task). By presenting the subject with different probability levels for reward receipt, the objective is to examine the extent to which the relationship between motivation (i.e., anhedonia) and effort-based decision-making is modulated by perceived reward magnitude.

    Time frame: 1 day

  2. Monetary Incentive Delay (MID) Task

    The MID is a behavioural paradigm that assesses the basis of anticipation and consumption of reward and punishment. Each run of the MID task consists of approximately 72 trials. The types of cues presented include: circles (indicating the potential to win money i.e., gain cue), squares (indicating the potential to lose money i.e., loss cue), and a triangle (indicating no money will be won or lost i.e., neutral cue). A cue is presented for 500 ms, followed by a fixation cross (2,000 to 2,500 ms) and then the target square (160 to 260 ms), during which the participant is instructed to press a button as quickly as possible to win or avoid losing money. A feedback screen (1,650 ms), in which the top number indicates the amount of money won or lost during that trial, and the bottom number indicates the participant's total amount, is presented at the end of each trial.

    Time frame: 1 day

  3. Probablistic Reward Task (PRT)

    The PRT is a behavioural paradigm that measures response bias and sensitivity to reward under variable conditions. In this task, a signal detection approach is used, whereby subjects must discriminate between two non-ambiguous stimuli displayed rapidly on a computer screen in order to receive a monetary reward. Unbeknownst to the subjects, correct identification of one stimulus is reinforced three times more frequently than the other stimulus. Under these experimental circumstances, healthy subjects reliably develop a response bias for the stimulus that is reinforced more frequently, regardless of which stimulus was actually presented. Thus, reward responsiveness assessed in this task reflects the rapid shaping of future behavioral choices based on prior reinforcement experiences.

    Time frame: 1 day

Secondary outcomes

  1. MRI/DTI

    The secondary outcome will be the association between the EEfRT and function reciprocity of the reward circuit/cognitive control network as measured by MRI/DTI. Subjects will be scanned using a 3.0-Tesla Signa HDx scanner with an 8-channel phased-array receiver coil consisting of a structural and functional neuroimaging, comprising: 1. Whole-brain 3-D T1-weighted Inversion-Recovery prepared Fast Spoiled Gradient-Echo anatomical scan 2. Whole-brain, T2\*-weighted BOLD echo planar imaging during awake resting state 3. Three runs of whole-brain, T2\*-weighted BOLD EPI series during task-based reward paradigm. Graph theoretical analysis will be used to assess functional connectivity of the default mode network, cognitive control network, affect network and reward network. Associations between obesity and alterations in functional connectivity will be the outcome of interest.

    Time frame: 1 day

07

Study locations

1 site
  • Canadian Rapid Treatment Centre of Excellence
    Mississauga, Ontario L5C 4E7, Canada
08

References and documents

Study documents

  • Protocol and statistical analysis plan · Mar 7, 2019
  • Informed consent form · Mar 8, 2019

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 29, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03939676
Lead sponsor
Brain and Cognition Discovery Foundation
Responsible party
Roger McIntyre (Executive Director, Brain and Cognition Discovery Foundation) — Principal investigator
First posted
May 7, 2019
Start date
Oct 30, 2019
Primary completion
Dec 15, 2020
Completion
Dec 15, 2020
Last update
Jul 29, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion